/ OCTENISEPT . / , , . , , .
|
25 , / 1 .
Cesra Arzneimittel GmbH & Co. KG
|
3694 .
|
! |
|
|
|
|
|
/ 100 , / 1 .
Paul Hartmann
|
|
|
|
. / 100 / 60 .
Merck
|
44828 .
|
! |
|
|
|
|
|
. /. 2 + 10 -. / 56 .
Abbott Lab.
|
|
|
|
. /. 0,5 + 2,5 -. / 28 .
Abbott Lab.
|
|
|
|
40 / 1 .
|
|
|
|
40 / 1 .
|
|
|
|
40 / 1 .
|
|
|
|
40 / 1 .
|
|
|
|
20 / 1 .
|
|
|
|
40 / 1 .
|
|
|
|
25 / 1 .
|
|
|
|
/. . 40 / 1 .
|
|
|
|
10 % 30 / 1 .
|
|
|
|
10 % 30 / 1 .
|
|
|
|
10%, 30 / 1 .
|
|
|
|
10 % 25 / 1 .
|
|
|
|
10 % 25 / 1 .
|
|
|
|
10 % 25 / 1 .
|
|
|
|
10 % 25 / 1 .
|
|
|
|
10 % 25 / 1 .
|
|
|
|
10 % 30 / 1 .
|
|
|
|
. / . 50 / 1 .
Bode Chemie
|
|
|
|
- . /. . 1 % . 10 / 1 .
|
|
|
|
- . /. . 1 % . 20 / 1 .
|
|
|
|
- /. . 0,01 % . 100 / 1 .
-
|
|
|
|
- 1000 . / 1 .
Schulke & Mayr
|
|
|
|
- 250 . / 1 .
Schulke & Mayr
|
|
|
|
. 50 . / 1 .
|
|
|
|
40 . / 1 .
|
|
|
|
40 . / 1 .
|
|
|
|
50 . / 1 .
|
|
|
|
. - /. . 500 / 1 .
Bode Chemie
|
|
|
|
. 5 000 / 1 .
|
|
|
|
. - . /. . 5000 / 1 .
Bode Chemie
|
|
|
|
. 1 000 / 1 .
|
|
|
|
- 5 / 1 .
Bode Chemie
|
|
|
|
- . /. . . . 100 / 1 .
|
|
|
|
. 475 / 1 .
|
|
|
|
- /. . . 25 / 1 .
|
|
|
|
- /. . . 25 / 1 .
|
|
|
|
. /. - . 2,5 / . 2 % / 10 .
|
|
|
|
- . 20 / . 20 2 % / 1 .
Homeocan
|
|
|
|
- . 20 / . 25 2 % / 1 .
Slayback Pharma LLC
|
|
|
|
- . 10 / . 100 1 % / 1 .
Slayback Pharma LLC
|
|
|
|
- . 10 / . 100 1 % / 1 .
Homeocan
|
|
|
